The Partners

• Fundacion centro tecnoloxico de telecomunicacions Galicia,
• Servizo Galego de saude (ES),
• IT Corporate solutions Spain SL (TR),
• Univerza v Mariboru (SI),
• Fakulteta za elektrotehniko, računalništvo in informatiko (SI),
• Univerzitetni klinični center Maribor (SI),
• Haute ecole specialisee de Suisse Occidentale (CH),
• Latvijas Universitate (LV),
• Cyberethics Lab SRLS (IT),
• Centre Hospitalier universitarie de Liege (BE),
• Symptoma GMBH (AT),
• RUBYNANOMED, UNIPESSOAL LDA (PT),
• National Patients Organisations (BG)

Description

Approved in the Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment call (SC1-DTH-01-2019), PERSIST will focus on the problems faced by patients who survive to breast and colorectal cancer. To this end, experts will develop an innovative ecosystem, based on AI and Big Data technologies to support the decision-making of physicians contributing to optimal treatment decisions.

The complete PERSIST system will incorporate, on the one hand, a clinical decision support system based on new models of health data analysis. On the other hand, a mHealth system for the remote and personalized monitoring of each patient.

In addition, the partners will develop a Big Data platform that integrates the two previous systems and will connect to the Electronic Health Records (EHRs) of any hospital.